Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412198
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-05-09
Brief Title:
A Multicenter Phase 1b2 Study of Adagrasib Cetuximab and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| KRAS G12C Mutations |
| Metastatic Colorectal Cancer |
Keywords: